02.22.21 -- How To Leverage Automation And Data To Optimize Your Process

Data generated during the development of biopharmaceuticals serves as an essential tool for process understanding, process control, continuous improvement, and filings. Addressing data management challenges during drug development requires an understanding of today’s shortcomings and the factors to consider when adopting a solution to overcome them.

Your automation strategy can be designed to expand with your business if you consider your choices in the initial stages. Early platform design selections can greatly affect your future flexibility and ability to show compliance throughout regulatory reviews.

For many years, manufacturing plants have been generating more and better data. Some companies have started harnessing this information to gain valuable insights that could improve efficiency, productivity, and growth. Recent advances in asset performance management owe much to the digital manufacturing revolution.

As a growing contract development and manufacturing organization (CDMO) for biologics and advanced therapies, Fujifilm Diosynth Biotechnologies recognized the criticality of flexibility and efficiency in manufacturing. Through a successful implementation, Fujifilm was able to not only recognize the benefits an integrated automation platform offers, but also the importance of working with an experienced partner.

With today’s complex manufacturing systems and processes, can a manufacturer afford to not have a centralized automation platform?